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Juvenile localized scleroderma, also known as morphea,
is the more frequent subtype of scleroderma in child-
hood. It comprises a group of distinct conditions which
involve the skin and subcutaneous tissues. They range
from very small plaques of fibrosis involving only the
skin, to diseases which may cause significant functional
and cosmetic deformity.
The most widely used classification divides JLS into five
general types: circumscribed morphea (CM), linear sclero-
derma, generalized morphea (GM), pansclerotic morphea
and the new mixed subtype where a combination of two
or more of the previous subtypes is present.
Circumscribed morphea (CM) is characterized by oval
or round circumscribed areas of induration surrounded by
a violaceous halo.
When there are four or more plaques with individual
plaques that are larger than 3 cm and they become conflu-
ent involving at least two out of seven anatomic sites
(head-neck, right upper extremity, left upper extremity,
right lower extremity, left lower extremity, anterior trunk,
posterior trunk) it is called Generalized Morphea (GM).
Linear scleroderma, the most common subtype in chil-
dren and adolescents, is characterized by one or more lin-
ear streaks that can extend through the dermis,
subcutaneous tissue, and muscle to the underlying bone,
causing significant deformities. The upper or lower extre-
mities can be affected but also the face or scalp, as in the
en coup de sabre variety (ECDS). The Parry Romberg syn-
drome (PRS), characterized by hemifacial atrophy of the
skin and tissue below the forehead, with mild or absent
involvement of the superficial skin is considered the severe
end of the spectrum of ECDS and for this reason is
included in subtype of linear scleroderma
Pansclerotic morphea, an extremely rare but severe
subtype, is characterized by generalized full-thickness
involvement of the skin of the trunk, extremities, face and
scalp with sparing of the fingertips and toes.
A recent multinational study reported that almost one
fourth of the patients present extra-cutaneous manifesta-
tions such as arthritis, neurological findings, associated
autoimmune conditions or ocular abnormalities. Antinuc-
lear antibodies (ANA) are present in more than 40% of
patients with JLS.
The management of JLS is challenging and the detection
of disease activity and progression remains a fundamental
problem. Clinical examination is subjective, classical skin
scoring methods, utilized in the assessment of systemic
sclerosis, cannot be applied. Among the new tools which
have been proposed for the assessment of the skin lesions,
infrared thermography (IRT), computerized skin score
(CSS), ultrasound (US) and magnetic resonance imaging
(MRI) are those most frequently used.
Over the years, many treatments have tried for loca-
lized scleroderma. Circumscribed morphea generally is
of cosmetic concern only, and therefore treatments with
potentially significant toxicity are not justified.
When there is a significant risk for disability, such as in
linear and deep subtypes, systemic treatment methotrex-
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